Xilio Therapeutics Inc. Gains 35.86%
Wed, Jan 25, 2023 at 06:59 PM
Xilio Therapeutics Inc. (XLO:NASDAQ) jumped higher at $3.94, representing a gain of 35.9%. On Wed, Jan 25, 2023, XLO:NASDAQ hit a New 2-Week High of $3.94. From Wed, Jan 11, 2023, the stock recorded 77.78% Up Days and 60.00% Green Days
About Xilio Therapeutics Inc. (XLO:NASDAQ)
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
Top 10 Gainers:
- Schmitt Industries, Inc. (SMIT:NASDAQ), 240.05%
- Minerva Surgical Inc. (UTRS:NASDAQ), 72.37%
- Alvarium Tiedemann Holdings Inc. (ALTI:NASDAQ), 65.41%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 46.43%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 40.83%
- Cidara Therapeutics, Inc. (CDTX:NASDAQ), 37.92%
- iPower Inc. (IPW:NASDAQ), 36.35%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 35.86%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 33.75%
- eHealth, Inc. (EHTH:NASDAQ), 32.29%